4
Changes in Ownership
Edesa Biotech, Inc. Filed Acc 0001144204-18-014750
Options or other derivatives
- Chief Financial Officer acquired 35,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| NIFFENEGGER KATHI Chief Financial Officer | 2018-03-12 | Grant or award · Share Option (Right to Buy) | +35,000 | 35,000 | D | ||
Loading xslF345X03/tv488519_4.xml…